Format

Send to

Choose Destination
Crit Care. 2016 Apr 28;20(1):109. doi: 10.1186/s13054-016-1263-z.

Current evidence for the effectiveness of heated and humidified high flow nasal cannula supportive therapy in adult patients with respiratory failure.

Author information

1
Critical Care Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Barcelona, Spain. oroca@vhebron.net.
2
Ciber Enfermedades Respiratorias (Ciberes), Instituto de Salud Carlos III, Madrid, Spain. oroca@vhebron.net.
3
Critical Care Department, Virgen de la Salud Hospital, Toledo, Spain.
4
Respiratory Medicine Department, Ramón y Cajal University Hospital, Madrid, Spain.
5
Emergency Medicine Department, Alicante General Hospital, Alicante, Spain.
6
Anesthesiology Department, De Cruces General Hospital, Bilbao, Spain.
7
Ciber Enfermedades Respiratorias (Ciberes), Instituto de Salud Carlos III, Madrid, Spain.
8
Critical Care Department, Del Mar University Hospital, IMIM (Medical Research del Mar Hospital Institute), Barcelona, Spain.

Abstract

High flow nasal cannula (HFNC) supportive therapy has emerged as a safe, useful therapy in patients with respiratory failure, improving oxygenation and comfort. Recently several clinical trials have analyzed the effectiveness of HFNC therapy in different clinical situations and have reported promising results. Here we review the current knowledge about HFNC therapy, from its mechanisms of action to its effects on outcomes in different clinical situations.

KEYWORDS:

High flow nasal cannula; High flow oxygen therapy; Respiratory failure

PMID:
27121707
PMCID:
PMC4848798
DOI:
10.1186/s13054-016-1263-z
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center